You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Kutaryaxmpa
Kutaryaxmpa is a biologic medication prescribed for the treatment of moderate to severe atopic dermatitis (eczema), chronic rhinosinusitis with nasal polyps, and asthma. It belongs to the class of monoclonal antibodies and works by targeting specific immune pathways involved in inflammation. By inhibiting these pathways, Kutaryaxmpa helps reduce inflammation, itching, and airway constriction. It is typically used when traditional treatments, such as topical corticosteroids or inhalers, are not effective enough.
Rx. Enter your prescription
How would you like to get your prescription? Select an option
Pharmacy pickup
Select from 35,000 pharmacies
Free two-day delivery
Coming soon!
Find a pharmacy near you. Enter your ZIP code
Are you a member? Sign up or log in.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
How much Bitcoin can you earn with Kutaryaxmpa ?
The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.
See the value of your savings today
Today's Value
1 Bitcoin = $NaN
Bitcoin (BTC)
...
USD
$NaN
Adjust Bitcoin's potential value to see how much it could be worth
Potential Value
1 Bitcoin =
Bitcoin (BTC)
...
USD
$NaN
Frequently Asked Questions
How long does it take for Kutaryaxmpa to start working?
Patients may begin to see improvements within the first 2-4 weeks of treatment, though full benefits might take longer to manifest.
Can Kutaryaxmpa be self-administered?
Yes, Kutaryaxmpa can be self-administered via pre-filled syringes or auto-injectors after receiving proper training from a healthcare provider.
What should I do if I miss a dose of Kutaryaxmpa?
If you miss a dose, take it as soon as you remember. If it is close to your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double up doses.
Can I take Kutaryaxmpa if I’m pregnant?
Kutaryaxmpa should only be used during pregnancy if the potential benefits outweigh the risks. Discuss your situation with your healthcare provider if you are pregnant or planning to become pregnant.
Are there any dietary restrictions while taking Kutaryaxmpa?
There are no specific dietary restrictions while taking Kutaryaxmpa. However, maintaining a balanced diet and avoiding allergens that may worsen your condition is always recommended.
Comprehensive Drug Guide
How Does Kutaryaxmpa Work?
Kutaryaxmpa works by targeting and inhibiting specific immune proteins, such as IL-4 and IL-13, that are involved in inflammatory responses. These cytokines play a central role in driving allergic and immune-related inflammation. By blocking these pathways, Kutaryaxmpa reduces symptoms such as itching, nasal congestion, and difficulty breathing, improving overall quality of life for patients with chronic allergic conditions.
Common Dosages
- Pre-filled syringes or auto-injectors: 200 mg, 300 mg
Typical Dosing
- For atopic dermatitis: The typical starting dose is 600 mg (two 300 mg injections), followed by 300 mg every 2 weeks.
- For asthma: The standard dose is 300 mg every 2 to 4 weeks, depending on the severity and patient response.
- For chronic rhinosinusitis with nasal polyps: 300 mg every 2 to 4 weeks, depending on the severity.
Typical Dosing
FDA Approved Indications
- Moderate to severe atopic dermatitis (eczema)
- Chronic rhinosinusitis with nasal polyps
- Moderate to severe asthma with an eosinophilic phenotype or dependent on oral corticosteroids
Who Shouldn't Take Kutaryaxmpa?
- Known hypersensitivity to Kutaryaxmpa or any of its components
- Active infections, particularly parasitic infections
- Current or untreated tuberculosis
Advice From The Pharmacist
- Kutaryaxmpa is administered as a subcutaneous injection, either by a healthcare provider or self-administered at home after proper training.
- Ensure to keep your appointments for regular injections, as missed doses can affect the effectiveness of the treatment.
- Store the medication in the refrigerator, and allow it to reach room temperature for about 30 minutes before injecting.
- Always consult your healthcare provider before receiving any live vaccines while on Kutaryaxmpa.
Side Effects of Kutaryaxmpa
Common Side Effects
- Injection site reactions (redness, swelling, pain)
- Headache
- Conjunctivitis (eye inflammation)
- Sore throat
Uncommon/Severe Side Effects
- Severe allergic reactions (anaphylaxis)
- Increased risk of infections, including parasitic infections
- Worsening of existing infections
Risks and Warnings of Kutaryaxmpa
- Infection Risk: Since Kutaryaxmpa affects the immune system, it may increase the risk of infections. Patients should be monitored closely for signs of infection, especially if they have a history of parasitic infections.
- Allergic Reactions: Serious allergic reactions, including anaphylaxis, have been reported. If you experience symptoms like rash, swelling, or difficulty breathing, discontinue use and seek medical attention immediately.
- Immunosuppression: Kutaryaxmpa may weaken the immune system, and patients should be cautious about infections or diseases that could worsen with immune suppression.
Interactions with Kutaryaxmpa
Common Drug Interactions
- Live vaccines: Live vaccines should be avoided while on Kutaryaxmpa, as the medication may reduce the body’s ability to respond to the vaccine.
- Immunosuppressive drugs: Combining Kutaryaxmpa with other immunosuppressive medications may increase the risk of infections.
Alternatives to Kutaryaxmpa
- Dupixent (dupilumab): Another monoclonal antibody used for atopic dermatitis, asthma, and nasal polyps.
- Xolair (omalizumab): A biologic treatment for allergic asthma and chronic hives.
- Nucala (mepolizumab): An IL-5 inhibitor used for severe eosinophilic asthma.
- Fasenra (benralizumab): Another IL-5 inhibitor used for severe asthma.
